Proven to stop infantile spasms*

My baby has spasms. Could it be infantile spasms?

Infantile spasms (IS) is a very rare condition that affects around 2500 infants and children each year. Spasms, however, are just part of the symptoms. If you suspect your child has IS, consult your doctor as soon as possible.

My baby was diagnosed with infantile spasms. How may Acthar help?

Acthar is an FDA-approved treatment that can be used to treat all types of IS. It has been shown in clinical trials to meet the goals for successful treatment set by 2 major organizations of neurology professionals.

My child's doctor has prescribed Acthar for infantile spasms. What's next?

As soon as your doctor prescribed Acthar, a support team went into action, coordinating coverage and delivery. Make sure your mobile phone is on. They'll be calling you.

We're home. Where can I go for support as I treat my child with Acthar?

The first few times you give your baby an Acthar injection at home, it's natural to have questions. You probably still have questions about IS too. Here's where the answers start.

Acthar for infantile spasms (IS)

Acthar is an FDA-approved medication for IS that contains ACTH (adrenocorticotropic hormone), a naturally occurring hormone, which has been proven to stop spasms and hypsarrhythmia in infants and children under 2 years of age with IS.

 

Meet Acthar Families

Stories of real families who have faced IS

Watch families share their experiences with identifying the disorder and completing treatment with Acthar.

Helpful Resources

Parent and Caregiver Brochure

Learn more about your child's IS and treatment with Acthar from this helpful and informative brochure.

Download your brochure

Acthar A.S.A.P.

See the many ways the Acthar Support & Access Program (A.S.A.P.) can help you get Acthar for your child with IS.

Learn how to give Acthar

Step-by-step videos help you walk through the administration process so you can learn, and then review, at your own pace.

*Acthar is an FDA-approved treatment that can be used to treat all types of IS. It has been shown in clinical trials to meet the goals for successful treatment set by 2 major organizations of neurology professionals.